Seasoned private markets executive focused on healthcare and growth-stage investing. Andrew Dziedzic brings operational and investment experience across venture and growth equity, advising portfolio companies on commercial scaling and capital strategy. He has worked across cross-border deals, corporate development and investor relations, with an analytical, growth-oriented investment approach.
Seasoned private markets executive focused on healthcare and growth-stage investing. Andrew Dziedzic brings operational and investment experience across venture and growth equity, advising portfolio companies on commercial scaling and capital strategy. He has worked across cross-border deals, corporate development and investor relations, with an analytical, growth-oriented investment approach.
Combines growth-stage, healthcare-focused capital deployment with an operator-investor mindset, prioritizing scalable commercial models and repeatable unit economics. Targets late-venture to growth equity opportunities where active governance and commercial scaling drive value; employs cross-border deal sourcing and corporate development levers to expand markets and strategic exits. Allocation favors concentrated, conviction-weighted positions with multi-year horizons, disciplined downside protection via milestone-based financing and hands-on portfolio support to accelerate revenue and de-risk commercial execution.
Combines growth-stage, healthcare-focused capital deployment with an operator-investor mindset, prioritizing scalable commercial models and repeatable unit economics. Targets late-venture to growth equity opportunities where active governance and commercial scaling drive value; employs cross-border deal sourcing and corporate development levers to expand markets and strategic exits. Allocation favors concentrated, conviction-weighted positions with multi-year horizons, disciplined downside protection via milestone-based financing and hands-on portfolio support to accelerate revenue and de-risk commercial execution.
| Trades 718 | Longs Won 550/718 76% | Profit Factor 21.82 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $233,180.89 |
| Average Win $77,210.11 | Best Trade (Mar 30) $3.88M | Sharpe Ratio -10.74 |
| Average Loss -$11,584.93 | Worst Trade (Aug 11) -$152,192.88 | Z-Score -5.93 (100%) |
| Commissions $0 | Avg. Trade Length 11m 2w | Expectancy $20,458.39 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 20,833 | 18,750 | 16,667 | 14,583 | 12,500 | 10,417 | 8,333 | 6,250 | 4,167 | 2,083 |